Page last updated: 2024-12-08

titanium phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

titanium phosphate: RN given refers to unspecified titanium phosphate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159761
MeSH IDM0111204

Synonyms (11)

Synonym
15578-51-5
trititanium tetrakis(phosphate)
titanium phosphate
einecs 239-641-8
phosphoric acid, titanium(4+) salt (4:3)
13765-94-1
phosphoric acid, titanium salt
JUWGUJSXVOBPHP-UHFFFAOYSA-B
titanium(4+);tetraphosphate
titanium(4+) phosphate (3/4)
DTXSID60929864
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (48)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (4.17)18.7374
1990's1 (2.08)18.2507
2000's15 (31.25)29.6817
2010's22 (45.83)24.3611
2020's8 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.65 (24.57)
Research Supply Index3.97 (2.92)
Research Growth Index5.77 (4.65)
Search Engine Demand Index48.20 (26.88)
Search Engine Supply Index1.95 (0.95)

This Compound (37.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (1.92%)4.05%
Observational0 (0.00%)0.25%
Other51 (98.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]